Iksuda Therapeutics deepens clinical pipeline through licensing agreement for Her2 antibody drug conjugate programme from LegoChem Biosciences.

By |2022-02-18T11:51:29+00:00January 10th, 2022|News|

Iksuda Therapeutics (Iksuda), the developer of a new generation of antibody drug conjugates (ADCs)… Continue Reading Iksuda Therapeutics deepens clinical pipeline through licensing agreement for Her2 antibody drug conjugate programme from LegoChem Biosciences.

Read Article
Comments Off on Iksuda Therapeutics deepens clinical pipeline through licensing agreement for Her2 antibody drug conjugate programme from LegoChem Biosciences.

Life science talent specialist RBW Consulting set to expand its thriving operation with new North East office

By |2022-01-06T10:42:07+00:00January 6th, 2022|News|

Life sciences talent and strategic consultancy, RBW Consulting, has today announced the opening of… Continue Reading Life science talent specialist RBW Consulting set to expand its thriving operation with new North East office

Read Article
Comments Off on Life science talent specialist RBW Consulting set to expand its thriving operation with new North East office

EU Logo
Northern Powerhouse Logo
NE LEP
Newcastle Council Logo
Newcastle Helix Logo

The Biosphere is part of the Newcastle Helix community.

It is part funded by the England European
Regional Development fund as part of the European Structural And Investment Funds Growth Programme 2014-2020 and the North East Local Growth Fund from HM Government, Administered by the North East Local Enterprise Partnership.

Get in touch
Request a callback
Skip to content
This Website is committed to ensuring digital accessibility for people with disabilitiesWe are continually improving the user experience for everyone, and applying the relevant accessibility standards.
Conformance status
Developed by AGHAI Web Development
Go to Top